8 completed, 3 terminated. 11 Phase 2.
By phase and status
Follow peginesatide: new trials by email Literature Review of peginesatide trials Research Report on peginesatide
Trials (filtered) newest first · largest first
All 11 trials
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix .
Trial Phase Status Sponsor Enrollment Start Updated
Efficacy and Safety of Peginesatide Injection for the Maintenance Treatment of Anemia in Peritoneal Dialysis Participants Previously Treated With Epoetin. Peginesatide - Anemia Phase 2 Completed 59 2008-10-01 2012-08-15 Safety and Efficacy of Peginesatide Injection for the Maintenance of Anemia in Chronic Renal Failure Participants Who Are on Hemodialysis or Do Not Require Dialysis and Previously Treated With Darbepoetin Alfa. Peginesatide - Anemia Phase 2 Completed 102 2008-09-01 2012-07-27 Safety & Efficacy of Peginesatide for Treatment of Anemia in Participants on Dialysis Not Receiving an ESA peginesatide, Epoetin Alfa - Anemia, Chronic Renal Failure Phase 2 Completed 114 2008-06-01 2012-06-29 Peginesatide for Maintenance Treatment of Anemia in Participants on Hemodialysis peginesatide - Anemia, Chronic Kidney Disease Phase 2 Completed 91 2006-12-01 2012-06-29 Extension Study to Evaluate Safety and Tolerability of Peginesatide for Long-Term Treatment of Anemia in Participants With CKD (EU) peginesatide - Chronic Renal Failure, Chronic Kidney Disease Phase 2 Terminated 114 2006-11-01 2012-06-29 Extension Study to Evaluate Safety and Tolerability of Peginesatide for Long-Term Treatment of Anemia in Participants With CKD peginesatide - Chronic Renal Failure, Chronic Kidney Disease Phase 2 Terminated 81 2006-09-01 2012-06-29 Efficacy and Safety of Peginesatide (AF37702) in the Treatment of Anemia in Participants With Chronic Kidney Disease Peginesatide - Anemia, Chronic Kidney Disease Phase 2 Completed 22 2006-04-06 2019-03-14 Study of Subcutaneously Administered Peginesatide in Anemic Cancer Patients Receiving Chemotherapy peginesatide - Chemotherapy Induced Anemia, Cancer Phase 2 Completed 60 2006-01-01 2012-12-21 Safety, PD & PK of Multiple Doses of Peginesatide for Anemia in Chronic Kidney Disease Patients peginesatide - Anemia, Chronic Kidney Disease Phase 2 Completed 139 2005-09-01 2012-12-21 Peginesatide for Anemia in Chronic Hemodialysis Patients peginesatide - Anemia, Chronic Kidney Disease Phase 2 Completed 165 2005-07-01 2012-12-21 Safety of Single Doses of Peginesatide in Patients With Chronic Kidney Disease Placebo, peginesatide - Anemia, Chronic Kidney Disease Phase 2 Terminated 17 2005-03-01 2012-12-21
Conditions studied Anemia (11) · Kidney Failure, Chronic (8) · Renal Insufficiency, Chronic (8) · Neoplasms (1) · Red-Cell Aplasia, Pure (1) · Renal Insufficiency (1)
Sponsors Affymax (8) · Takeda (3)
Countries United Kingdom (7) · United States (4) · Poland (3) · Bulgaria (2) · Romania (2) · Australia (1) · Czechia (1) · France (1) · Germany (1) · Italy (1) · New Zealand (1) · Russia (1)
Top investigators Vice President, Clinical Development (4)
Results publications PMID 19890127 , PMID 21940838 , PMID 22935486
NIH funding 2005 (4) , 2008 (2)